Insight

Native Hawaiian and Pacific Islander populations and higher rates of inflammatory breast cancer – NCI Center for Cancer Research

Photo taken from NCI Center for Cancer Research/LinkedIn

Jun 22, 2024, 19:01

Native Hawaiian and Pacific Islander populations and higher rates of inflammatory breast cancer – NCI Center for Cancer Research

NCI Center for Cancer Research shared a post on LinkedIn:

“NEW FINDINGS: A CCR study found that Native Hawaiian and Pacific Islander populations had higher rates of inflammatory breast cancer (IBC) and poor survival in non-IBC when compared to other races/ethnic groups. More research is needed to understand the factors and improve outcomes.

These findings were largely spearheaded by Takeo Fujii, M.D., M.P.H., and team. Dr. Fujii is a medical oncologist and a physician-scientist who specializes in breast cancer and metastasis. His research focuses on finding novel therapeutic targets to breast cancer brain metastasis by understanding the role of inflammation and immune cells in the tumor microenvironment.”

Native Hawaiian

Source: NCI Center for Cancer Research/LinkedIn
.

Breast Cancer breast cancer metastasis cancer cancer outcomes Cancer research cancer survival rates IBC immune cells inflammation inflammatory breast cancer Native Hawaiian Native Hawaiian and Pacific Islander populations NCI Center for Cancer Research novel therapeutic targets OncoDaily Oncology Pacific Islander racial disparities Research Takeo Fujii tumor microenvironment

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 10

OncoThon 2024 Raises $1.3 Million for Pediatric Cancer Research

Remembering Virgil Abloh: Louis Vuitton’s Creative Director Honored at 41 After His Brave Battle with Cardiac Angiosarcoma

Richard Sullivan: The State of Global Cancer Surgery from Political and Equity Perspectives

Immunotherapy for Bladder Cancer: Types, Success Rate, Side Effects & More

Special Coverage